Crossmark

Precision medicine in the era of CRISPR-Cas9: evidence from Bosnia and Herzegovina

Crossref DOI link: https://doi.org/10.1057/s41599-019-0346-2

Published Online: 2019-10-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Semiz, Sabina https://orcid.org/0000-0003-2629-4660
Aka, Philip C.
License Information

Text and Data Mining valid from 2019-10-29

Version of Record valid from 2019-10-29
More Information

Article History

Received: 25 July 2019

Accepted: 8 October 2019

First Online: 29 October 2019

Competing interests

: The authors declare no competing interests.